Showing 1-1 of 1

Sorted By:

  • Melanoma: S1320

    The purpose of this study is to compare any good and bad effects of receiving the drugs dabrafenib and trametinib continuously to receiving dabrafenib and trametinib with a break in treatment for patients with BRAF mutant melanoma.

Page InfoPage
Showing trial 1 of 1

View Additional Section Content

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email